

EU Court Sides with NYT in Pfizer Vaccine Documents Case
European Court Rules Against Commission in Pfizer Transparency Case Brussels, Belgium – A European court has ruled against the European Commission in a case brought by the New York Times. The Times sought the release of correspondence between the Commission and Pfizer concerning COVID-19 vaccine procurement. The court found that the Commission's refusal to release the documents was unjustified. The case highlights concerns about transparency and accountability in the handling of the pandemic. The New York Times argued that the public has a right to know about the details of the vaccine contracts. "The public deserves to know how these decisions were made," a spokesperson for the New York Times stated. The European Commission has not yet commented on the ruling. The decision could set a precedent for future cases involving government transparency. The ruling underscores the importance of open access to information regarding public health emergencies.